The effectiveness of this intervention can be explained in the context of the inflammatory hypothesis of schizophrenia by the inhibition of the COX-2 enzyme by aspirin, which decreases the concentration of kynurenic acid and its metabolites in the CNS. The gene discussed is PTGS2; the disease is schizophrenia.